Investor Alert

Market Pulse Archives

Jan. 27, 2020, 7:31 a.m. EST

PPD sets IPO terms, to be valued at $9.2 billion

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    PPD Inc. (PPD)
  • X
    Renaissance IPO ETF (IPO)
  • X
    Health Care Select Sector SPDR ETF (XLV)

or Cancel Already have a watchlist? Log In

By Tomi Kilgore

PPD Inc. /zigman2/quotes/204871412/composite PPD -0.87% said Monday terms of its initial public offering have been set, as the North Carolina-based drug development services provider for the biopharmaceutical industry looks to raise up to $1.62 billion. The company said it is offering 60 million shares in the IPO, which is expected to price between $24 and $27 a share. With 339.4 million shares to be outstanding after the IPO, PPD could be valued at up to $9.16 billion. The stock is expected to list on the Nasdaq under the ticker symbol "PPD." Barclays, J.P. Morgan, Morgan Stanley and Goldman Sachs are the lead underwriters. The company reported net income of $47.9 million on revenue of $2.98 billion for the nine months ended Sept. 30, after income of $59.7 million on revenue of $2.77 billion in the same period a year ago. The company is looking to go public at a time that the Renaissance IPO ETF /zigman2/quotes/207665280/composite IPO -3.67% has rallied 14.6% over the past three months, while the SPDR Health Care Select Sector ETF /zigman2/quotes/205918244/composite XLV -3.40% has advanced 11.3% and the S&P 500 /zigman2/quotes/210599714/realtime SPX -4.42% has gained 9.0%.

US : U.S.: Nasdaq
$ 28.56
-0.25 -0.87%
Volume: 1.12M
Feb. 27, 2020 4:00p
P/E Ratio
Dividend Yield
Market Cap
$10.04 billion
Rev. per Employee
US : U.S.: NYSE Arca
$ 31.51
-1.20 -3.67%
Volume: 57,879
Feb. 27, 2020 6:30p
US : U.S.: NYSE Arca
$ 93.82
-3.30 -3.40%
Volume: 22.05M
Feb. 27, 2020 6:30p
-137.63 -4.42%
Volume: 3.94B
Feb. 27, 2020 5:20p

This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.